Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?

Detalhes bibliográficos
Autor(a) principal: Ferrari,Andrés Di Leoni
Data de Publicação: 2014
Outros Autores: Borges,Anibal Pires, Albuquerque,Luciano Cabral, Sussenbach,Carolina Pelzer, Rosa,Priscila Raupp da, Piantá,Ricardo Medeiros, Wiehe,Mario, Goldani,Marco Antônio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Cardiovascular Surgery (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402
Resumo: Implantable cardiac pacing systems are a safe and effective treatment for symptomatic irreversible bradycardia. Under the proper indications, cardiac pacing might bring significant clinical benefit. Evidences from literature state that the action of the artificial pacing system, mainly when the ventricular lead is located at the apex of the right ventricle, produces negative effects to cardiac structure (remodeling, dilatation) and function (dissinchrony). Patients with previously compromised left ventricular function would benefit the least with conventional right ventricle apical pacing, and are exposed to the risk of developing higher incidence of morbidity and mortality for heart failure. However, after almost 6 decades of cardiac pacing, just a reduced portion of patients in general would develop these alterations. In this context, there are not completely clear some issues related to cardiac pacing and the development of this cardiomyopathy. Causality relationships among QRS widening with a left bundle branch block morphology, contractility alterations within the left ventricle, and certain substrates or clinical (previous systolic dysfunction, structural heart disease, time from implant) or electrical conditions (QRS duration, percentage of ventricular stimulation) are still subjecte of debate. This review analyses contemporary data regarding this new entity, and discusses alternatives of how to use cardiac pacing in this context, emphasizing cardiac resynchronization therapy.
id SBCCV-1_cdd55e22ca3f7e54ae8164f8d1f33b32
oai_identifier_str oai:scielo:S0102-76382014000300402
network_acronym_str SBCCV-1
network_name_str Brazilian Journal of Cardiovascular Surgery (Online)
repository_id_str
spelling Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?Pacemaker, ArtificialCardiomyopathy, DilatedVentricular DysfunctionImplantable cardiac pacing systems are a safe and effective treatment for symptomatic irreversible bradycardia. Under the proper indications, cardiac pacing might bring significant clinical benefit. Evidences from literature state that the action of the artificial pacing system, mainly when the ventricular lead is located at the apex of the right ventricle, produces negative effects to cardiac structure (remodeling, dilatation) and function (dissinchrony). Patients with previously compromised left ventricular function would benefit the least with conventional right ventricle apical pacing, and are exposed to the risk of developing higher incidence of morbidity and mortality for heart failure. However, after almost 6 decades of cardiac pacing, just a reduced portion of patients in general would develop these alterations. In this context, there are not completely clear some issues related to cardiac pacing and the development of this cardiomyopathy. Causality relationships among QRS widening with a left bundle branch block morphology, contractility alterations within the left ventricle, and certain substrates or clinical (previous systolic dysfunction, structural heart disease, time from implant) or electrical conditions (QRS duration, percentage of ventricular stimulation) are still subjecte of debate. This review analyses contemporary data regarding this new entity, and discusses alternatives of how to use cardiac pacing in this context, emphasizing cardiac resynchronization therapy.Sociedade Brasileira de Cirurgia Cardiovascular2014-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402Brazilian Journal of Cardiovascular Surgery v.29 n.3 2014reponame:Brazilian Journal of Cardiovascular Surgery (Online)instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)instacron:SBCCV10.5935/1678-9741.20140104info:eu-repo/semantics/openAccessFerrari,Andrés Di LeoniBorges,Anibal PiresAlbuquerque,Luciano CabralSussenbach,Carolina PelzerRosa,Priscila Raupp daPiantá,Ricardo MedeirosWiehe,MarioGoldani,Marco Antônioeng2014-10-29T00:00:00Zoai:scielo:S0102-76382014000300402Revistahttp://www.rbccv.org.br/https://old.scielo.br/oai/scielo-oai.php||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br1678-97410102-7638opendoar:2014-10-29T00:00Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)false
dc.title.none.fl_str_mv Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
title Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
spellingShingle Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
Ferrari,Andrés Di Leoni
Pacemaker, Artificial
Cardiomyopathy, Dilated
Ventricular Dysfunction
title_short Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
title_full Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
title_fullStr Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
title_full_unstemmed Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
title_sort Cardiomyopathy induced by artificial cardiac pacing: myth or reality sustained by evidence?
author Ferrari,Andrés Di Leoni
author_facet Ferrari,Andrés Di Leoni
Borges,Anibal Pires
Albuquerque,Luciano Cabral
Sussenbach,Carolina Pelzer
Rosa,Priscila Raupp da
Piantá,Ricardo Medeiros
Wiehe,Mario
Goldani,Marco Antônio
author_role author
author2 Borges,Anibal Pires
Albuquerque,Luciano Cabral
Sussenbach,Carolina Pelzer
Rosa,Priscila Raupp da
Piantá,Ricardo Medeiros
Wiehe,Mario
Goldani,Marco Antônio
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ferrari,Andrés Di Leoni
Borges,Anibal Pires
Albuquerque,Luciano Cabral
Sussenbach,Carolina Pelzer
Rosa,Priscila Raupp da
Piantá,Ricardo Medeiros
Wiehe,Mario
Goldani,Marco Antônio
dc.subject.por.fl_str_mv Pacemaker, Artificial
Cardiomyopathy, Dilated
Ventricular Dysfunction
topic Pacemaker, Artificial
Cardiomyopathy, Dilated
Ventricular Dysfunction
description Implantable cardiac pacing systems are a safe and effective treatment for symptomatic irreversible bradycardia. Under the proper indications, cardiac pacing might bring significant clinical benefit. Evidences from literature state that the action of the artificial pacing system, mainly when the ventricular lead is located at the apex of the right ventricle, produces negative effects to cardiac structure (remodeling, dilatation) and function (dissinchrony). Patients with previously compromised left ventricular function would benefit the least with conventional right ventricle apical pacing, and are exposed to the risk of developing higher incidence of morbidity and mortality for heart failure. However, after almost 6 decades of cardiac pacing, just a reduced portion of patients in general would develop these alterations. In this context, there are not completely clear some issues related to cardiac pacing and the development of this cardiomyopathy. Causality relationships among QRS widening with a left bundle branch block morphology, contractility alterations within the left ventricle, and certain substrates or clinical (previous systolic dysfunction, structural heart disease, time from implant) or electrical conditions (QRS duration, percentage of ventricular stimulation) are still subjecte of debate. This review analyses contemporary data regarding this new entity, and discusses alternatives of how to use cardiac pacing in this context, emphasizing cardiac resynchronization therapy.
publishDate 2014
dc.date.none.fl_str_mv 2014-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0102-76382014000300402
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.5935/1678-9741.20140104
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
publisher.none.fl_str_mv Sociedade Brasileira de Cirurgia Cardiovascular
dc.source.none.fl_str_mv Brazilian Journal of Cardiovascular Surgery v.29 n.3 2014
reponame:Brazilian Journal of Cardiovascular Surgery (Online)
instname:Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
instname_str Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron_str SBCCV
institution SBCCV
reponame_str Brazilian Journal of Cardiovascular Surgery (Online)
collection Brazilian Journal of Cardiovascular Surgery (Online)
repository.name.fl_str_mv Brazilian Journal of Cardiovascular Surgery (Online) - Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
repository.mail.fl_str_mv ||rosangela.monteiro@incor.usp.br|| domingo@braile.com.br|| brandau@braile.com.br
_version_ 1752126598556942336